CTA
DVAX

Carillon Tower Advisers’s Dynavax Technologies DVAX Stock Holding History

Carillon Tower Advisers’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,636,176
Closed -$6.53M – 474
2019
Q2 		$6.53M Hold
1,636,176
– – 0.04% 372
2019
Q1 		$12M Hold
1,636,176
– – 0.08% 311
2018
Q4 		$15M Hold
1,636,176
– – 0.13% 249
2018
Q3 		$20.3M Hold
1,636,176
– – 0.15% 232
2018
Q2 		$25M Buy
+1,636,176
New +$28.3M 0.2% 181

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCPEMI
Bain Capital Public Equity Management II Boston, Massachusetts $62.1M AUM 25.46% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Carillon Tower Advisers's DVAX Position: Q3 2019 in Review

Carillon Tower Advisers sold out of Dynavax Technologies (DVAX) in Q3 2019, closing a stake of 1,636,176 shares — an estimated $6.53M sold.

Carillon Tower Advisers first reported a position in DVAX in Q2 2018 and held it in 5 quarters. The position peaked at $25M in Q2 2018. 117 funds tracked by Wall St. Rank hold DVAX as of Q3 2019.

  • Carillon Tower Advisers reported no remaining Dynavax Technologies position as of Q3 2019 after selling out during the quarter.
  • Carillon Tower Advisers sold 1,636,176 Dynavax Technologies shares in Q3 2019, an estimated $6.53M.
  • Carillon Tower Advisers first reported a position in Dynavax Technologies in Q2 2018 and held it in 5 quarters.
  • Carillon Tower Advisers's Dynavax Technologies position peaked at $25M in Q2 2018.
  • 117 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2019.

Based on Carillon Tower Advisers's 13F filing for Q3 2019, filed 5 Nov 2019.